Intraventricular gliomas

Neurosurgery Clinics of North America

Volumn 14, Issue 4, 2003, Pages 571-591

  Dumont, Aaron S ^a,b   Farace, Elana ^b   Schiff, David ^b   Shaffrey, Mark E ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 (2 CHLOROETHYL) 3 (2,6 DIOXO 3 PIPERIDYL) 1 NITROSOUREA; ANTINEOPLASTIC AGENT; CARBOPLATIN; CARMUSTINE; CHLORMETHINE; CISPLATIN; CYCLOPHOSPHAMIDE; ETOPOSIDE; IDARUBICIN; IFOSFAMIDE; LOMUSTINE; MITOLACTOL; PREDNISONE; PROCARBAZINE; TEMOZOLOMIDE; THIOTEPA; VINCRISTINE;

ADOLESCENT; ADULT; ASTROCYTOMA; BRAIN TUMOR; BRAIN VENTRICLE TUMOR; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CHILD; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; EPENDYMOMA; GIANT CELL TUMOR; GLIOMA; HISTOLOGY; HUMAN; INCIDENCE; INFANT; INTRACRANIAL HYPERTENSION; NEUROPATHOLOGY; NEURORADIOLOGY; NEUROSURGERY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT POSITIONING; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SUBEPENDYMOMA; SURGICAL APPROACH;

EID: 0348148958     PISSN: 10423680     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1042-3680(03)00062-7     Document Type: Review

References (159)

1. Sato K, Kubota T, Ishida M, Yoshida K, Takeuchi H, Handa Y. Immunohistochemical and ultrastructural study of chordoid glioma of the third ventricle: its tanycytic differentiation. Acta Neuropathol (Berl) 2003;106(2):176-80.
2. Grand S, Pasquier B, Gay E, Kremer S, Remy C, Le Bas JF. Chordoid glioma of the third ventricle: CT and MRI, including perfusion data. Neuroradiology 2002;44(10):842-6.
3. Pasquier B, Peoc'h M, Morrison AL, Gay E, Pasquier D, Grand S, et al. Chordoid glioma of the third ventricle: a report of two new cases, with further evidence supporting an ependymal differentiation, and review of the literature. Am J Surg Pathol 2002;26(10):1330-42.
4. Lee TT, Manzano GR. Third ventricular glioblastoma multiforme: case report. Neurosurg Rev 1997;20(4):2914.
5. Guibaud L, Champion F, Buenerd A, Pelizzari M, Bourgeois J, Pracros JP. Fetal intraventricular glioblastoma: ultrasonographic, magnetic resonance imaging, and pathologic findings. J Ultrasound Med 1997;16(4):285-8.
6. Jaeger M, Hussein S, Schuhmann MU, Brandis A, Samii M, Blomer U. Intraventricular trigonal ganglioglioma arising from the choroids plexus. Acta Neurochir (Wien) 2001;143(9):953-5.
7. Dyer S, Prebble E, Davison V, Davies P, Ramani P, Ellison D, et al. Genomic imbalances in pediatric intracranial ependymomas define clinically relevant groups. Am J Pathol 2002;161:2133-41.
8. Granzow M, Popp S, Weber S, Schoell B, Holtgreve-Grez H, Senf L, et al. Isochromosome 1q as an early genetic event in a child with intracranial ependymoma characterized by molecular cytogenetics. Cancer Genet Cytogenet 2001; 130(1):79-83.
9. Hirose Y, Aldape K, Bollen A, James CD, Brat D, Lamborn K, et al. Chromosomal abnormalities subdivide ependymal tumors into clinically relevant groups. Am J Pathol 2001;158:1137-43.
10. Singh PK, Gutmann DH, Fuller CE, Newsham IF, Perry A. Differential involvement of protein 4.1 family members DAL-1 and NF2 in intracranial and intraspinal ependymomas. Mod Pathol 2002; 15(5):526-31.
11. Virchow RLK. Cellular pathology as based upon physiology and pathological histology. Philadelphia: JB Lippincott. 1971. [Chance F, Trans.; original work published 1863.]
12. Fokes E, Earle K. Ependymomas: clinical and pathological aspects. J Neurosurg 1969;30:585-94.
13. Gurney JG, Severson RK, Davis S, Robison LL. Incidence of cancer in children in the United States. sex-, race-, and 1-year age-specific rates by histologic type. Cancer 1995;75:2186-95.
14. Helseth A, Mork SJ. Neoplasms of the central nervous system in Norway: IIl. Epidemiological characteristics of intracranial gliomas according to histology. APMIS 1989;97:547-55.
15. Kuratsu J, Ushio Y. Epidemiological study of primary intracranial tumors in childhood. Pediatr Neurosurg 1996;25:240-7.
16. Miller RW, Young JL, Novakovic B. Childhood cancer. Cancer 1995;75:395-405.
17. Svien H, Mabon R, Kernohan J, et al. Ependymoma of the brain: pathological aspects. Neurology 1953;3:1-15.
18. Birgisson S, Blondal H, Bjornsson J, et al. Tumours in Iceland: 15. Ependymoma: a clinicopathological and immunohistological study. APMIS 1992;100:294-300.
19. Goldwein JW, Leahy JM, Packer RJ, et al. Intracranial ependymomas in children. Int J Radiat Oncol Biol Phys 1990;19:1497-502.
20. Robertson PL, Zeltzer PM, Boyett JM, et al. Survival and prognostic factors following radiation therapy and chemotherapy for ependymomas in children: a report of the Children's Cancer Group. J Neurosurg 1998;88:695-703.
21. Gilles FH, Sobel EL, Tavare CJ, et al. Age-related changes in diagnoses, histological features, and survival in children with brain tumors: 1930-1979. The Childhood Brain Tumor Consortium. Neurosurgery 1995;37:1056-68.
22. Nazar GB, Hoffman HJ, Becker LE, et al. Infratentorial ependymomas in childhood: prognostic factors and treatment. J Neurosurg 1990;72:408-17.
23. Polednak AP, Flannery JT. Brain, other central nervous system, and eye cancer. Cancer 1995;75:330-7.
24. Rousseau P, Habrand JL, Sarrazin D, et al. Treatment of intracranial ependymomas in children: review of a 15-year experience. Int J Radiat Oncol Biol Phys 1994;28:381-6.
25. Vernet O, Farmer JP, Meagher-Villemure K, et al. Supratentorial ectopic ependymoma. Can J Neurol Sci 1995;22:316-9.
26. Ernestus RI, Schroder R, Klug N. Spontaneous intracerebral hemorrhage from an unsuspected ependymoma in early infancy. Childs Nerv Syst 1992;8:357-60.
27. Naidich T, Lin J, Leeds N, et al. Primary tumors and other masses of the cerebellum and fourth ventricle: differential by computed tomography. Neuroradiology 1977;14:53-74.
28. Centeno RS, Lee AA, Winter J, et al. Supratentorial ependymomas: neuroimaging and clinicopathological correlation. J Neurosurg 1986;64:209-15.
29. Swartz J, Zimmerman R, Bilaniuk L. Computed tomography of intracranial ependymomas. Radiology 1982;143:97-101.
30. Armington WG, Osborn AG, Cubberley DA, et al. Supratentorial ependymoma: CT appearance. Radiology 1985;157:367-72.
31. Spoto GP, Press GA, Hesselink JR, et al. Intracranial ependymoma and subependymoma: MR manifestations. AJNR Am J Neuroradiol 1990;11:83-91.
32. Choi JY, Chang KH, Yu IK, et al. Intracranial and spinal ependymomas: review of MR images in 61 patients. Korean J Radiol 2002;3(4):219-28.
33. Kleihues P, Cavenee WK, editors. World Health Organization classification of tumours. Pathology and genetics of tumours of the nervous system. Lyon: IARC Press; 2000.
34. Ikezaki K, Matsushima T, Inoue T, et al. Correlation of microanatomical localization with postoperative survival in posterior fossa ependymomas. Neurosurgery 1993;32:38-44.
35. Lyons MK, Kelly PJ. Posterior fossa ependymomas; report of 30 cases and review of the literature. Neurosurgery 1991;28:659-65.
36. Paulino AC, Wen BC. Buatti JM, et al. Intracranial ependymomas. An analysis of prognostic factors and patterns of failure. Am J Clin Oncol 2002;25(2):117-22.
37. van Veelen-Vincent MC, Pierre-Kahn A, Kalifa C, et al. Ependymoma in childhood: prognostic factors, extent of surgery, and adjuvant therapy. J Neurosurg 2002;97:827-35.
38. Ernestus RI, Wilcke O, Schroder R. Supratentorial ependymomas in childhood: clinicopathological findings and prognosis. Acta Neurochir (Wien) 1991;111:96-102.
39. Sutton LN, Goldwein J, Perilongo G, et al. Prognostic factors in childhood ependymomas. Pediatr Neurosurg 1990;16:57-65.
40. Pierre-Kahn A, Hirsch J, Roux F, et al. Intracranial ependymomas in childhood: survival and functional results of 47 cases. Childs Brain 1983;10:145-56.
41. Undjian S, Marinov M. Intracranial ependymomas in children. Childs Nerv Syst 1990;6:131-4.
42. Kovalic JJ, Flaris N, Grigsby PW, et al. Intracranial ependymoma long term-outcome, patterns of failure. J Neurooncol 1993;15:125-31.
43. Palma L, Celli P, Cantore G. Supratentorial ependymomas of the first two decades of life: long-term follow-up of 20 cases (including two subependymomas). Neurosurgery 1993;32:169-75.
44. Fokes E, Earle K. Ependymomas: clinical and pathological aspects. J Neurosurg 1969;30:585-94.
45. Mork S, Loken A. Ependymoma: a follow-up study of 100 cases. Cancer 1977;40:907-15.
46. Perilongo G, Massimino M, Sotti G, et al. Analyses of prognostic factors in a retrospective review of 92 children with ependymoma: Italian Pediatric Neurooncology Group. Med Pediatr Oncol 1997;29:79-85.
47. Phillips TL, Sheline GE, Boldrey E. Therapeutic consideration in tumors affecting the central nervous system: ependymomas. Radiology 1964; 83:98-105.
48. Kim Y, Fayos JV. Intracranial ependymomas. Therapeut Radiol 1977;124:805-8.
49. Garrett PG, Simpson WJK. Ependymomas; results of radiation therapy. Int J Radiat Oncol Biol Phys 1983;9:1121-4.
50. Kun LE, Kovnar EH, Sanford RA. Ependymomas in children. Pediatr Neurosci 1988;14:57-63.
51. Leibel SA, Sheline GE. Radiation therapy for neoplasms of the brain. J Neurosurg 1987;66:1-22.
52. Wallner KE, Wara WM, Sheline GE, et al. Intracranial ependymomas: results of treatment with partial or whole brain irradiation without spinal irradiation. Int J Radiat Oncol Biol Phys 1986;12:937-41.
53. Stafford SL, Pollock BE, Foote RL, et al. Stereotactic radiosurgery for recurrent ependymoma. Cancer 2000;88:870-5.
54. Oya S, Shibamoto Y, Nagata Y, et al. Post-operative radiotherapy for intracranial ependymoma: analysis of prognostic factors and patterns of failure. J Neurooncol 2002;56(1):87-94.
55. Salazar OM, Castro-Vita H, Van Houtte P, et al. Improved survival in cases of intracranial ependymoma after radiation therapy. Late report and recommendations. J Neurosurg 1983;59:652-9.
56. Hoppe-Hirsch E, Brunet L, Laroussinie F, et al. Intellectual outcome in children with malignant tumors of the posterior fossa: influence of the field of irradiation and quality of surgery. Childs Nerv Syst 1995;11:340-5.
57. Scheurlen W, Kuhl J. Current diagnostic and therapeutic management of CNS metastasis in childhood primitive neuroectodermal tumors and ependymomas. J Neurooncol 1998;28:181-5.
58. Merchant TE, Haida T, Wang MH, et al. Anaplastic ependymoma: treatment of pediatric patients with or without craniospinal radiation therapy. J Neurosurg 1997;86:943-9.
59. Goldwein JW, Corn BW, Finlay JL, et al. Is craniospinal irradiation required to cure children with malignant (anaplastic) ependymoma? Cancer 1991;67:2766-71.
60. Heideman RL, Packer RJ, Reaman GH, et al. A phase II evaluation of thiotepa in pediatric central nervous system malignancies. Cancer 1993;72:271-275.
61. Salazar OM. A better understanding of CNS seeding and a brighter outlook for postoperatively irradiated patients with ependymomas. Int J Radiat Oncol Biol Phys 1983;9:1231-4.
62. Palma L, Celli P, Mariottini A, et al. The importance of surgery in supratentorial ependymomas. Long-term survival in a series of 23 cases. Childs Nerv Syst 2000;16:170-5.
63. Douek E, Kingston JE, Malpas JS, et al. Platinum-based chemotherapy for recurrent CNS tumors in young patients. J Neurol Neurosurg Psychiatry 1991;54:722-5.
64. Lesser GJ, Grossman SA. The chemotherapy of adult primary brain tumors. Cancer Treat Rev 1993;19:261-81.
65. Strauss LC, Killmond TM, Carson BS, et al. Efficacy of postoperative chemotherapy using cisplatin plus etoposide in young children with brain tumors. Med Pediatr Oncol 1991;19:16-21.
66. Tamura M, Ono N, Kurihara H, et al. Adjunctive treatment for recurrent childhood ependymoma of the IV ventricle: chemotherapy with CDDP and MCNU. Childs Nerv Syst 1990;6:186-9.
67. van Eys J, Cangir A, Coody D, et al. MOPP regimen as primary chemotherapy for brain tumors in infants. J Neurooncol 1985;3:237-43.
68. Lefkowitz I, Evans A, Sposto R, et al. Adjuvant chemotherapy of childhood posterior fossa ependymoma: craniospinal irradiation with or without CCNU, vincristine, and prednisone. Proc Am Soc Clin Oncol 1989;8:87.
69. Ater JL, van Eys J, Woo SY, et al. MOPP chemotherapy without irradiation as primary post-surgical therapy for brain tumors in infants and young children. J Neurooncol 1997;32:243-52.
70. White L, Johnston H, Jones R, et al. Postoperative chemotherapy without radiation in young children with malignant non-astrocytic brain tumours, A report from the Australia and New Zealand Childhood Cancer Group (ANZCCSG). Cancer Chemother Pharmacol 1993;32:403-6.
71. Geyer JR, Zeltzer PM, Boyett JM, et al. Survival of infants with primitive neuroectodermal tumors or malignant ependymomas of the CNS treated with eight drugs in 1 day: a report from the Children's Cancer Group. J Clin Oncol 1994; 12:1607-15.
72. Ayan I, Darendeliler E, Kebudi R, et al. Evaluation of response to postradiation eight in one chemotherapy in childhood brain tumors. J Neurooncol 1995;26:65-72.
73. Evans AE, Anderson JR, Lefkowitz-Boudreaux IB, et al. Adjuvant chemotherapy of childhood posterior fossa ependymoma: cranio-spinal irradiation with or without adjuvant CCNU, vincristine, and prednisone: a Children's Cancer Group study. Med Pediatr Oncol 1996;27:8-14.
74. Needle MN, Goldwein JW, Grass J, et al. Adjuvant chemotherapy for the treatment of intracranial ependymoma of childhood. Cancer 1997;80:341-7.
75. Duffner PK, Krischer JP, Sanford RA, et al. Prognostic factors in infants and very young children with intracranial ependymomas. Pediatr Neurosurg 1998;28:215-22.
76. Bouffet E, Foreman N. Chemotherapy for intracranial ependymomas. Childs Nerv Syst 1999; 15:563-70.
77. Bertolone SJ, Baum ES, Krivit W, et al. A phase II study of cisplatin therapy in recurrent childhood brain tumors: a report from the Children's Cancer Study Group. J Neurooncol 1989;7:5-11.
78. Corden BJ, Strauss LC, Killmond T, et al. Cisplatin, ara-C and etoposide (PAE) in the treatment of recurrent childhood brain tumors. J Neurooncol 1991;11:57-63.
79. Sexauer CL, Khan A, Burger PC, et al. Cisplatin in recurrent pediatric brain tumors: A POG Phase II study - a Pediatric Oncology Group Study. Cancer 1985;56:1497-501.
80. Levin VA. Chemotherapy of primary brain tumors. Neurol Clin 1985;3:855-66.
81. Shapiro WR. Chemotherapy of primary malignant brain tumors in children. 1975. Cancer 1975; 35(Suppl):965-72.
82. Gaynon PS, Ettinger LJ, Baum ES, et al. Carboplatin in childhood brain tumors. A Children's Cancer Study Group Phase II trial. Cancer 1990; 66:2465-9.
83. Friedman HS, Krisher JP, Burger P, et al. Treatment of children with progressive or recurrent brain tumors with carboplatin or iproplatin: a Pediatric Oncology Group randomized phase II study. J Clin Oncol 1992;10:249-56.
84. Allen JC, Hancock C, Walker R, et al. PCNU and recurrent childhood brain tumors. J Neurooncol 1987;5:241-4.
85. Ragab AH, Burger P, Badnitsky S, et al. BCNU in the treatment of recurrent medulloblastoma and ependymoma - a POG study. J Neurooncol 1986; 2:341-2.
86. Chastagner P, Sommelet OD, Kalifa C, et al. Phase II study of ifosfamide in childhood brain tumors: a report by the French Society of Pediatric Oncology (SFOP). Med Pediatr Oncol 1993;21:49-53.
87. Heideman RL, Douglass EC, Langston JA, et al. Phase II study of every other day high-dose ifosfamide in pediatric brain tumors: a Pediatric Oncology Group study. J Neurooncol 1995;25:77-84.
88. Heidman RL, Packer RJ, Allen JC. A phase II study of thiopental in pediatric central nervous system tumors. Pediatr Neurosci 1989;15:146-7.
89. Razzouk BI, Heidman RL, Friedman HS, et al. A phase II evaluation of thiotepa followed by other multiagent chemotherapy regimens in infants and young children with malignant brain tumors. Cancer 1995;75:2762-7.
90. Schold SC Jr, Friedman HS, Bjornsson TD, et al. Treatment of patients with recurrent primary brain tumors with AZQ. Neurology 1984;34:615-9.
91. Ettinger LJ, Ru N, Krailo M, et al. A phase II study of diaziquone in children with recurrent or progressive primary brain tumors: a report from the Children's Cancer Study Group. J Neurooncol 1990;9:69-76.
92. Arndt C, Krailo MD, Steinherz L, et al. A phase II clinical trial of idarubicin administered to children with relapsed brain tumors. Cancer 1998;83:813-6.
93. Pendergrass TW, Milstein JM, Geyer JR, et al. Eight drugs in one day chemotherapy for brain tumors: experience in 107 children and rationale for preradiation chemotherapy. J Clin Oncol 1993; 5:1221-3.
94. Ettinger LJ, Sinniah D, Siegel SE. Combination chemotherapy with cyclophosphamide, vincristine, procarbazine, and prednisone (COPP) in children with brain tumors. J Neurooncol 1985;3:263-9.
95. Mason WP, Goldman S, Yates AJ, et al. Survival following intensive chemotherapy with bone marrow reconstitution for children with recurrent intracranial ependymoma-a report of the Children's Cancer Group. J Neurooncol 1998; 37:135-43.
96. Grill J, Kalifa C, Doz F, et al. A high-dose busulfan-thiotepa combination followed by autologous bone marrow transplantation in childhood recurrent ependymoma. A phase-II study. Pediatr Neurosurg 1996;25:7-12.
97. Duffner PK, Cohen ME, Myers MH, et al. Survival of children with brain tumors: SEER Program, 1973-1980. Neurology 1986;36:597-601.
98. Papadopoulos DP, Giri S, Evans RG. Prognostic factors and management of intracranial ependymomas. Anticancer Res 1990;10:689-92.
99. Vanuytsel LJ, Bessell EM, Ashley SE, et al. Intracranial ependymoma: long-term results of a policy of surgery and radiotherapy. Int J Radiat Oncol Biol Phys 1992;23:313-9.
100. Pollack IF, Gerszten PC, Martinez AJ, et al. Intracranial ependymomas of childhood: longterm outcome and prognostic factors. Neurosurgery 1995;37:655-66.
101. Healey EA, Barnes PD, Kupsky WJ, et al. The prognostic significance of postoperative residual tumor in ependymoma. Neurosurgery 1991;28:666-71.
102. Guyotat J, Signorelli F, Desme S, et al. Intracranial ependymomas in adult patients: analyses of prognostic factors. J Neurooncol 2002;60(3):255-68.
103. Rorke LB. Relationship of morphology of ependymoma in children to prognosis. Prog Exp Tumor Res 1987;30:170-4.
104. Shaw EG, Evans RG, Scheithauer BW, et al. Postoperative radiotherapy of intracranial ependymoma in pediatric and adult patients. Int J Radiat Oncol Biol Phys 1987;13:1457-62.
105. Figarell-Branger D, Gambarelli D, et al. Infratentorial ependymomas of childhood. Correlation between histological features, immunohistological phenotype, silver nucleolar organizer region staining values and postoperative survival in 16 cases. Acta Neuropathol (Berl) 1991;82:208-16.
106. Schiffer D, Chio A, Cravioto H, et al. Ependymoma: internal correlations among pathological signs: the anaplastic variant. Neurosurgery 1991; 29:206-10.
107. Chiu JK, Woo SY, Ater J, et al. Intracranial ependymoma in children: analysis of prognostic factors. J Neurooncol 1992;13:283-90.
108. Ross GW, Rubinstein LJ. Lack of histopathological correlation of malignant ependymomas with postoperative survival. J Neurosurg 1989;70:31-6.
109. Marks JE, Adler SJ. A comparative study of ependymomas by site of origin. Int J Radiat Oncol Biol Phys 1982;8:37-43.
110. Jayawickreme DP, Hayward RD, Harkness WF. Intracranial ependymomas in childhood: a report of 24 cases followed for 5 years. Childs Nerv Syst 1995;11:409-13.
111. Pierre-Kahn A, Hirsch JF, Roux FX, et al. Intracranial ependymomas in childhood. Survival and functional results of 47 cases. Childs Brain 1983;10:145-56.
112. Scheithauer BW. Symptomatic subependymoma: report of 21 cases with review of the literature. J Neurosurg 1978;49:689-96.
113. Scheinker IM. Subependymoma: a newly recognized tumor of subependymal derivation. J Neurosurg 1945;2:232-40.
114. Clarenbach P, Kleihues P, Metzel E, Dichgans J. Simultaneous manifestation clinical manifestation of subependymoma of the fourth ventricle in identical twins: case report. J Neurosurg 1979;50:655-9.
115. Honan WP, Anderson M, Carey MP, et al. Familial subependymomas. Br J Neurosurg 1987; 1:317-21.
116. Ryken T, Robinson R, VanGilder J. Familial occurrence of subependymoma. J Neurosurg 1994;80:1108-11.
117. Ho KL. Concurrence of subependymoma and heterotopic leptomeningeal neuroglial tissue. Arch Pathol Lab Med 1983;107:136-40.
118. Russell D, Rubinstein L. Tumors of central neuroepithelial origin. In: Russell DS, Rubinstein LJ, editors. Pathology of the central nervous system. Baltimore: Williams & Wilkins; 1989. p. 192-206.
119. Chanson JL. Subependymal mixed gliomas. J Neuropathol Exp Neurol 1956;15:461-70.
120. Hashimoto M, Tanaka H, Oguro K, Masuzawa T. Subependymoma of the lateral ventricle: case report. Neurol Med Chir (Tokyo) 1991;31:732-5.
121. Matsumura A, Ahyai A, Hori A, Schaake T. Intracerebral subependymomas: clinical and neuropathological analyses with special reference to the possible existence of a less benign variant. Acta Neurochir (Wien) 1989;96:15-25.
122. Scheithauer BW, Bruner JM. Central nervous system tumors. Clin Lab Med 1987;7:157-79.
123. Jelenik J, Smirniotopoulos JG, Parisi JE, Kanzer M. Lateral ventricular neoplasms of the brain: differential diagnosis based on clinical, CT, and MR findings. AJNR Am J Neuroradiol 1990; 11:567-74.
124. Nishio S, Morioka T, Mihara F, Fukui M. Subependymoma of the lateral ventricles. Neurosurg Rev 2000;23:98-103.
125. Ortiz-Reyes R, Dragovic L, Eriksson A. Sudden unexpected death resulting from previously non-symptomatic subependymoma. Am J Forensic Med Pathol 2002;23:63-7.
126. Changaris DG, Powers JM, Perot PL Jr, Hungerford GD, Neal GB. Subependymoma presenting as subarachnoid hemorrhage: case report. J Neurosurg 1981;55:643-5.
127. French JD, Bucy PC. Tumors of the septum pellucidum. J Neurosurg 1948;5:433-49.
128. Azarelli B, Rekate HL, Roessmann U. Subependymoma: a case report with ultrastructural study. Acta Neuropathol (Berl) 1977;40:279-82.
129. Rengachary SS. Subependymomas. In: Wilkins RH, Rengachary SS, editors. Neurosurgery. New York: McGraw-Hill; 1996. p. 1201-3.
130. Chiechi MV, Smirniotopoulos JG, Jones RV. Intracranial subependymomas: CT and MR imaging features in 24 cases. AJR Am J Roentgenol 1995;165:1245-50.
131. Hoeffel C, Boukobza M, Polivka M, Lot G, Guichard JP, Lafitte F, et al. MR manifestations of subependymomas. AJNR Am J Neuroradiol 1995;16:2121-9.
132. Godwin JT. Subependymal glomerate astrocytoma: report of two cases. J Neurosurg 1959; 16:385-9.
133. Prayson RA, Suh JH. Subependymomas: clinico-pathologic study of 14 tumors, including comparative MIB-1 immunohistochemical analysis with other ependymal neoplasms. Arch Pathol Lab Med 1999;123:306-9.
134. Louis DN, Hedley-Whyte ET, Martuza RL. Case report: sarcomatous proliferation of the vasculature in subependymoma. Acta Neuropathol (Berl) 1989;78:332-5.
135. Rosenblum MK, Erlanson RA, Aleksic SN, Budsilovich GN. Melanotic ependymoma and subependymoma. Am J Surg Pathol 1990;14:729-36.
136. Tomlinson FH, Scheithauer BW, Kelly PJ, Gorbes GS. Subependymoma with rhabdomyosarcomatous differentiation: report of a case and literature review. Neurosurgery 1991;28:761-8.
137. Artico M, Bardella L, Ciapetta P, Raco A. Surgical treatment of subependymomas of the central nervous system. Report of 8 cases and review of the literature. Acta Neurochir (Wien) 1989;98:25-31.
138. Marsh WR, Laws E Jr. Intracranial ependymomas. Prog Exp Tumor Res 1987;30:175-80.
139. Frerebeau P, Benezech J, Segnarbieux F, Harbi H, Desy A, Marty-Double C. Intraventricular tumors in tuberous sclerosis. Childs Nerv Syst 1985; 1:45-8.
140. Sima AAF, Robertson DM. Subependymal giant-cell astrocytoma: case report with ultrastructural study. J Neurosurg 1979;50:240-5.
141. Shepherd CW, Scheithauer BW, Gomez MR, Altermatt HJ, Katzmann JA. Subependymal giant cell astrocytoma: a clinical, pathological, and flow cytometric study. Neurosurgery 1991; 28:864-8.
142. Padmalatha C, Harruff RC, Ganick D, Hafez GR. Glioblastoma multiforme with tuberous sclerosis. Arch Pathol Lab Med 1980;104:649-50.
143. Chou TM, Chou SM. Tuberous sclerosis in the premature infant: a report of a case with immunohistochemistry on the CNS. Clin Neuropathol 1989;8:45-52.
144. Holanda FJ, Holanda GM. Tuberous sclerosis: neurosurgical implications in intraventricular tumors. Neurosurg Rev 1980;3:139-50.
145. Winter J. Computed tomography in diagnosis of intracranial tumors versus tubers in tuberous sclerosis. Acta Radiol 1982;23:337-44.
146. Lee BCP, Gawler J. Tuberous sclerosis: comparison of computed tomography and conventional neuroradiology. Radiology 1978;127:403-7.
147. Martin N, Debussche C, DeBroucker T, Mompoint D, Marsault C, Nahum H. Gadolinium-DTPA enhanced MR imaging in tuberous sclerosis. Neuroradiology 1990;31:492-7.
148. Russell DS, Rubinstein LJ. Pathology of tumors of the central nervous system 5th edition. Baltimore: Williams & Wilkins; 1989. p. 116-7.
149. Morimoto K, Mogami H. Sequential CT study of subependymal giant-cell astrocytoma associated with tuberous sclerosis. Case report. J Neurosurg 1986;65:874-7.
150. Nishio S, Morioka T, Suzuki S, Kira R, Mijhara F, Fukui M. Subependymal giant cell astrocytoma: clinical and neuroimaging features of four cases. J Clin Neurosci 2001;8(1):831-4.
151. Lopes MBS, Altermatt HJ, Scheithauer BW, Shepherd CW, VandenBerg SR. Immunohistochemical characterization of subependymal giant cell astrocytomas. Acta Neuropathol (Berl) 1996; 91:368-75.
152. Scheithauer BW. The neuropathology of tuberous sclerosis. J Dermatol 1992;19:897-903.
153. Nakamura Y, Becker LE. Subependymal giant-cell tumor. Acta Neuropathol (Berl) 1983;60:271-7.
154. Bonnin JM, Rubinstein LJ, Papasozomenos SC, Marangos PJ. Subependymal giant cell astrocytoma. Significance and possible cytogenetic implications of an immunohistochemical study. Acta Neuropathol (Berl) 1984;62:185-93.
155. Gyure KA, Prayson RA. Subependymal giant cell astrocytoma: a clinicopathologic study with HMB45 and MIB-1 immunohistochemical analysis. Mod Pathol 1997;10:313-7.
156. Painter MJ, Pang D, Ahdab-Barmada M, Bergman I. Connatal brain tumors in patients with tuberous sclerosis. Neurosurgery 1984;14:570-3.
157. Yamamoto K, Yamada K, Nakahara T, Ishihara A, Takaki S, Kochi M, et al. Rapid regrowth of solitary subependymal giant cell astrocytoma: case report. Neurol Med Chir (Tokyo) 2002;42:224-7.
158. Brat DJ, Scheithauer BR, Staugaitis SM, et al. Third ventricular chordoid glioma: a distinct clinicopathologic entity. J Neuropathol Exp Neurol 1998;57:283-90.
159. Garza-Mercado R, Campa H, Grajeda J. Primary oligodendroglioma of the septum pellucidum. Neurosurgery 1987;21:78-80.